cyclosporine has been researched along with Eyelid Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, Y; Eom, Y; Kim, HM; Park, SY; Rhim, JW; Song, JS; Yoon, EG | 1 |
| Downie, LE; Keller, PR | 1 |
| Gregory, DG | 1 |
| Akiyama, M; Fujita, Y; Inokuma, D; Kasai, S; Kase, S; Lin, HY; Minakawa, H; Ono, K; Saito, N; Shimizu, H; Yamane, N; Yanagi, T | 1 |
| Calonge, M; Hileeto, D; Muñoz-Sanz, A; Murillo, G; Ramírez, B; Romo, LA | 1 |
| Bron, AJ; Foulks, GN; Holland, EJ; McDonald, MB; Nelson, JD; Nichols, KK | 1 |
| Mahawong, W; Prabhasawat, P; Tesavibul, N | 1 |
| McLoon, LK; Ozel, B; Wirtschafter, J | 1 |
| Bernhard, JD; Person, JR | 1 |
2 review(s) available for cyclosporine and Eyelid Diseases
| Article | Year |
|---|---|
A Pragmatic Approach to the Management of Dry Eye Disease: Evidence into Practice.
Topics: Cyclosporine; Dry Eye Syndromes; Evidence-Based Practice; Eyelid Diseases; Female; Humans; Immunosuppressive Agents; Lacrimal Apparatus; Lubricant Eye Drops; Meibomian Glands; Middle Aged; Precision Medicine; Quality of Life; Young Adult | 2015 |
Pyoderma gangrenosum of the eyelid: report of two cases and review of the literature.
Topics: Aged; Cyclosporine; Drug Therapy, Combination; Eyelid Diseases; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Prednisolone; Pyoderma Gangrenosum | 2010 |
2 trial(s) available for cyclosporine and Eyelid Diseases
| Article | Year |
|---|---|
Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction.
Topics: Cyclosporine; Dry Eye Syndromes; Eyelid Diseases; Humans; Hyaluronic Acid; Meibomian Gland Dysfunction; Meibomian Glands; Ophthalmic Solutions; Prospective Studies; Tears | 2022 |
A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
Topics: Administration, Topical; Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Emulsions; Eyelid Diseases; Female; Fluorescein; Humans; Immunosuppressive Agents; Male; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Staining and Labeling; Tears; Treatment Outcome | 2012 |
5 other study(ies) available for cyclosporine and Eyelid Diseases
| Article | Year |
|---|---|
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity | 2016 |
Oculopalpebral borreliosis as an unusual manifestation of Lyme disease.
Topics: Adolescent; Antibodies, Bacterial; Azathioprine; Borrelia burgdorferi; Corneal Ulcer; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Eye Infections, Bacterial; Eyelid Diseases; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Lyme Disease; Vasculitis | 2013 |
Improving awareness, identification, and management of meibomian gland dysfunction.
Topics: Adult; Cyclosporine; Dry Eye Syndromes; Eyelid Diseases; Female; Humans; Keratomileusis, Laser In Situ; Lacrimal Apparatus Diseases; Male; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Tears; Visual Acuity | 2012 |
Cyclosporin protects the eyelid skin from injury after injection of doxorubicin.
Topics: Animals; Blepharospasm; Cyclosporine; Doxorubicin; Eyelid Diseases; Eyelids; Facial Muscles; Injections; Muscle Denervation; Oculomotor Muscles; Rabbits; Skin; Skin Diseases; Spasm | 1995 |
Facial and eyelid psoriasis after cyclosporin withdrawal.
Topics: Cyclosporine; Eyelid Diseases; Facial Dermatoses; Humans; Male; Middle Aged; Psoriasis; Substance Withdrawal Syndrome | 1991 |